Patents by Inventor Xiaoling Song
Xiaoling Song has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20250091641Abstract: Provided herein is a system and method for monitoring the health of a steering system of a vehicle. Methods can include: receiving location information and motion information associated with a vehicle; determining, from the location information, a map-matched road segment associated with the location information; establishing a geometry of the map-matched road segment based on map data of a map database; filtering the motion information associated with the vehicle to establish a baseline movement of the vehicle; determining, during the baseline movement of the vehicle, steering angle input received at a steering system of the vehicle; determining, from the steering angle input received at the steering system of the vehicle, a steering angle offset; and causing the steering angle offset to be applied to the steering system of the vehicle.Type: ApplicationFiled: September 13, 2024Publication date: March 20, 2025Inventors: Zongzheng LI, Jinghui SONG, Haimo BI, Xiaoling HAN, Michael Scott DONALDSON
-
Hybridoma cell line of secreting cyproheptadine monoclonal antibodies and preparation method thereof
Patent number: 12247085Abstract: A hybridoma cell line of secreting cyproheptadine monoclonal antibodies with a preservation number of CGMCC No. 14699 belongs to the field of food safety immunological detection. BALB/c mice are immunized through one time immunization with complete freund's adjuvant, three times of booster immunization with incomplete freund's adjuvant and one time of rush immunization with cyproheptadine complete antigen without adjuvant; the spleen cells from BALB/C mice immunized with high potency and low value of IC50 are fused with murine myeloma cells; and then the hybridoma cell line is obtained through indirect competitive ELISA screening and three sub-clones. The monoclonal antibody secreted by this cell line has good specificity and detection sensitivity to cyproheptadine (value of IC50 is 0.37 ng/ml), being suitable for detection of cyproheptadine in food.Type: GrantFiled: December 27, 2022Date of Patent: March 11, 2025Assignee: JIANGNAN UNIVERSITYInventors: Chuanlai Xu, Hua Kuang, Wei Jiang, Liguang Xu, Wei Ma, Liqiang Liu, Xiaoling Wu, Shanshan Song, Yongming Hu -
Publication number: 20250064837Abstract: The present disclosure relates to compounds of formula (I) and their anti-tumor uses, and their intermediates of formula (III), and uses of the intermediates. The compound of formula (I) has a degrading effect on a specific target protein, which is mainly composed of three parts. The first part is a small molecule compound (SMBP, Small Molecules Binding Protein) that can bind to a protein, the second part LIN is a linker, and the three-part ULM is a ubiquitin ligand (ULM, Ubiquitin Ligase Binding Moiety), wherein SMBP is covalently bound to LIN, and LIN is covalently bound to ULM. A series of compounds designed and synthesized in the present disclosure have a wide range of pharmacological activities, including the functions of degrading specific proteins and/or inhibiting activities of specific proteins, and thus can be used in related tumor treatments.Type: ApplicationFiled: October 22, 2024Publication date: February 27, 2025Applicant: ShanghaiTech UniversityInventors: Xiaobao Yang, Biao Jiang, Renhong Sun, Chaowei Ren, Ning Sun, Ying Kong, Yan Li, Jinju Chen, Qianqian Yin, Xiaoling Song, Quanju Zhao, Xing Qiu
-
Patent number: 12226424Abstract: The present disclosure relates to compounds of formula (I) and their anti-tumor uses, and their intermediates of formula (III), intermediates of formula (IV), and uses of the intermediates. The compound of formula (I) has a degrading effect on a specific target protein, which is mainly composed of three parts. The first part is a small molecule compound (SMBP, Small Molecules Binding Protein) that can bind to a protein, the second part LIN is a linker, and the three-part ULM is a ubiquitin ligand (ULM, Ubiquitin Ligase Binding Moiety), wherein SMBP is covalently bound to LIN, and LIN is covalently bound to ULM. A series of compounds designed and synthesized in the present disclosure have a wide range of pharmacological activities, including the functions of degrading specific proteins and/or inhibiting activities of specific proteins, and thus can be used in related tumor treatments.Type: GrantFiled: April 9, 2019Date of Patent: February 18, 2025Assignee: ShanghaiTech UniversityInventors: Xiaobao Yang, Biao Jiang, Renhong Sun, Chaowei Ren, Ning Sun, Ying Kong, Yan Li, Jinju Chen, Qianqian Yin, Xiaoling Song, Quanju Zhao, Xing Qiu
-
Patent number: 11771709Abstract: A compound of formula (I) and its antitumor application are disclosed. The compounds of formula (I) have degradation and inhibitory effects on ALK target proteins. They are mainly composed of four parts: the first part, ALK-TKI, being compounds with ALK tyrosine kinase inhibitory activity; the second part, LIN, being different kinds of linker (Linker); the third part, the ULM, being a small molecule ligand (ULM, ubiquitin ligase binding moiety) with ubiquitination of VHL, CRBN or other proteases; and the fourth part, the group A, being a carbonyl group or absent, which covalently bond ALK-TKI to LIN, wherein LIN and ULM are covalently bonded. A series of compounds designed and synthesized by the present disclosure have wide pharmacological activities, have functions of degrading ALK protein and inhibiting ALK activity, and can be used for related tumor treatment.Type: GrantFiled: June 15, 2020Date of Patent: October 3, 2023Assignee: ShanghaiTech UniversityInventors: Xiaobao Yang, Biao Jiang, Xiaoling Song, Haifan Lin, Ning Sun, Jinju Chen, Xing Qiu, Chaowei Ren, Ying Kong
-
Publication number: 20220313829Abstract: A bifunctional compound, or a pharmaceutically acceptable salt, an isomer, a prodrug, a polymorphic substance or a solvate thereof. The chemical structural formula of the bifunctional compound is represented as formula I, and the bifunctional compound can be used for preventing or treating cancers.Type: ApplicationFiled: August 5, 2020Publication date: October 6, 2022Inventors: Xiaobao YANG, Biao JIANG, Xiaoling SONG, Ning SUN, Chaowei REN, Renhong SUN, Xiaojuan QU, Haixia LIU, Xing QIU
-
Publication number: 20220257776Abstract: A compound of general formula (I), a compound of general formula (III) and anti-tumor applications thereof. A series of compounds designed and synthesized have a wide range of pharmacological activities, have the function of degrading specific proteins and/or inhibiting activity, and can be used in related tumor and cancer treatments.Type: ApplicationFiled: June 11, 2020Publication date: August 18, 2022Inventors: Xiaobao YANG, Biao JIANG, Xiaoling SONG, Ning SUN, Chaowei REN, Ying KONG, Jianshui ZHANG, Jinju CHEN, Yan LI, Yuedong ZHOU
-
Publication number: 20220154287Abstract: The invention provides methods, nucleic acids and kits for detecting, or for detecting and distinguishing between or among liver cell proliferative disorders or for detecting, or for detecting and distinguishing between or among colorectal cell proliferative disorders. The invention discloses genomic sequences the methylation patterns of which have utility for the improved detection of and differentiation between said class of disorders, thereby enabling the improved diagnosis and treatment of patients.Type: ApplicationFiled: October 28, 2021Publication date: May 19, 2022Inventors: Catherine E. LOFTON-DAY, Andrew Z. SLEDZIEWSKI, Ralf LESCHE, Matthias SCHUSTER, Juergen DISTLER, Reimo TETZNER, Thomas HILDMANN, Fabian MODEL, Xiaoling SONG
-
Publication number: 20220117982Abstract: The present disclosure relates to compounds of formula (I) and their anti-tumor uses, and their intermediates of formula (III), intermediates of formula (IV), and uses of the intermediates. The compound of formula (I) has a degrading effect on a specific target protein, which is mainly composed of three parts. The first part is a small molecule compound (SMBP, Small Molecules Binding Protein) that can bind to a protein, the second part LIN is a linker, and the three-part ULM is a ubiquitin ligand (ULM, Ubiquitin Ligase Binding Moiety), wherein SMBP is covalently bound to LIN, and LIN is covalently bound to ULM. A series of compounds designed and synthesized in the present disclosure have a wide range of pharmacological activities, including the functions of degrading specific proteins and/or inhibiting activities of specific proteins, and thus can be used in related tumor treatments.Type: ApplicationFiled: April 9, 2019Publication date: April 21, 2022Applicant: ShanghaiTech UniversityInventors: Xiaobao Yang, Biao Jiang, Renhong Sun, Chaowei Ren, Ning Sun, Ying Kong, Yan Li, Jinju Chen, Qianqian Yin, Xiaoling Song, Quanju Zhao, Xing Qiu
-
Patent number: 11186879Abstract: The invention provides methods, nucleic acids and kits for detecting, or for detecting and distinguishing between or among liver cell proliferative disorders or for detecting, or for detecting and distinguishing between or among colorectal cell proliferative disorders. The invention discloses genomic sequences the methylation patterns of which have utility for the improved detection of and differentiation between said class of disorders, thereby enabling the improved diagnosis and treatment of patients.Type: GrantFiled: June 26, 2019Date of Patent: November 30, 2021Assignee: EPIGENOMICS AGInventors: Catherine E. Lofton-Day, Andrew Z. Sledziewski, Ralf Lesche, Matthias Schuster, Juergen Distler, Reimo Tetzner, Thomas Hildmann, Fabian Model, Xiaoling Song
-
Patent number: 11061028Abstract: This disclosure provides antigen compositions useful for diagnosing Lyme disease and for detecting antibodies that bind to Borrelia antigens. The antigenic compositions comprise a mixture of hybrid peptides and Borrelia proteins. This disclosure also provides devices, methods, and kits that are useful for diagnosing Lyme disease and for detecting anti-Borrelia antibodies in a sample to aid in the diagnosis of Lyme disease.Type: GrantFiled: September 23, 2015Date of Patent: July 13, 2021Assignee: Defined Diagnostics, LLCInventors: Nina Lukinova, Xiaoling Song, Paul Francis Macomber, Jill Ann White
-
Publication number: 20200306273Abstract: A compound of formula (I) and its antitumor application are disclosed. The compounds of formula (I) have degradation and inhibitory effects on ALK target proteins. They are mainly composed of four parts: the first part, ALK-TKI, being compounds with ALK tyrosine kinase inhibitory activity; the second part, LIN, being different kinds of linker (Linker); the third part, the ULM, being a small molecule ligand (ULM, ubiquitin ligase binding moiety) with ubiquitination of VHL, CRBN or other proteases; and the fourth part, the group A, being a carbonyl group or absent, which covalently bond ALK-TKI to LIN, wherein LIN and ULM are covalently bonded. A series of compounds designed and synthesized by the present disclosure have wide pharmacological activities, have functions of degrading ALK protein and inhibiting ALK activity, and can be used for related tumor treatment.Type: ApplicationFiled: June 15, 2020Publication date: October 1, 2020Applicant: ShanghaiTech UniversityInventors: Xiaobao Yang, Biao Jiang, Xiaoling Song, Haifan Lin, Ning Sun, Jinju Chen, Xing Qiu, Chaowei Ren, Ying Kong
-
Publication number: 20190316210Abstract: The invention provides methods, nucleic acids and kits for detecting, or for detecting and distinguishing between or among liver cell proliferative disorders or for detecting, or for detecting and distinguishing between or among colorectal cell proliferative disorders. The invention discloses genomic sequences the methylation patterns of which have utility for the improved detection of and differentiation between said class of disorders, thereby enabling the improved diagnosis and treatment of patients.Type: ApplicationFiled: June 26, 2019Publication date: October 17, 2019Inventors: Catherine E. Lofton-Day, Andrew Z. Sledziewski, Ralf Lesche, Matthias Schuster, Juergen Distler, Reimo Tetzner, Thomas Hildmann, Fabian Model, Xiaoling Song
-
Patent number: 10385402Abstract: The invention provides methods, nucleic acids and kits for detecting, or for detecting and distinguishing between or among liver cell proliferative disorders or for detecting, or for detecting and distinguishing between or among colorectal cell proliferative disorders. The invention discloses genomic sequences the methylation patterns of which have utility for the improved detection of and differentiation between said class of disorders, thereby enabling the improved diagnosis and treatment of patients.Type: GrantFiled: March 23, 2016Date of Patent: August 20, 2019Assignee: EPIGENOMICS AGInventors: Catherine E. Lofton-Day, Andrew Z. Sledziewski, Ralf Lesche, Matthias Schuster, Juergen Distler, Reimo Tetzner, Thomas Hildmann, Fabian Model, Xiaoling Song
-
Publication number: 20180149648Abstract: This disclosure provides antigen compositions useful for diagnosing Lyme disease and for detecting antibodies that bind to Borrelia antigens. The antigenic compositions comprise a mixture of hybrid peptides and Borrelia proteins. This disclosure also provides devices, methods, and kits that are useful for diagnosing Lyme disease and for detecting anti-Borrelia antibodies in a sample to aid in the diagnosis of Lyme disease.Type: ApplicationFiled: September 23, 2015Publication date: May 31, 2018Inventors: Nina LUKINOVA, Xiaoling SONG, Paul Francis MACOMBER, Jill Ann WHITE
-
Patent number: 9926573Abstract: Disclosed is a glyphosate-tolerant gene. The nucleotide sequence of the gene is SEQ ID NO: 1, SEQ ID NO: 3 or SEQ ID NO: 5, and a mutant form of the gene that maintains the glyphosate-tolerant activity. The amino acid sequence of a protein encoded by the gene is respectively SEQ ID NO: 2, SEQ ID NO: 4, or SEQ ID NO: 6, and a mutant form of amino acids in a conserved region 1 of positions 280 to 294 and in a conserved region 2 of positions 416 to 433. Also disclosed is the use of the gene and the mutant form thereof in the production of a glyphosate-resistant/tolerant plant.Type: GrantFiled: September 5, 2013Date of Patent: March 27, 2018Assignee: NANJING AGRICULTURAL UNIVERSITYInventors: Sheng Qiang, Chanjuan Mao, Shiguo Chen, Weimin Dai, Xiaoling Song
-
Patent number: 9695478Abstract: The invention provides methods, nucleic acids and kits for detecting, or for detecting and distinguishing between or among liver cell proliferative disorders or for detecting, or for detecting and distinguishing between or among colorectal cell proliferative disorders. The invention discloses genomic sequences the methylation patterns of which have utility for the improved detection of and differentiation between said class of disorders, thereby enabling the improved diagnosis and treatment of patients.Type: GrantFiled: May 13, 2010Date of Patent: July 4, 2017Assignee: EPIGENOMICS AGInventors: Catherine E. Lofton-Day, Andrew Z. Sledziewski, Ralf Lesche, Matthias Schuster, Juergen Distler, Reimo Tetzner, Thomas Hildmann, Fabian Model, Xiaoling Song
-
Publication number: 20160340689Abstract: Disclosed is a glyphosate-tolerant gene. The nucleotide sequence of the gene is SEQ ID NO: 1, SEQ ID NO: 3 or SEQ ID NO: 5, and a mutant form of the gene that maintains the glyphosate-tolerant activity. The amino acid sequence of a protein encoded by the gene is respectively SEQ ID NO: 2, SEQ ID NO: 4, or SEQ ID NO: 6, and a mutant form of amino acids in a conserved region 1 of positions 280 to 294 and in a conserved region 2 of positions 416 to 433. Also disclosed is the use of the gene and the mutant form thereof in the production of a glyphosate-resistant/tolerant plant.Type: ApplicationFiled: September 5, 2013Publication date: November 24, 2016Applicant: NANJING AGRICULTURAL UNIVERSITYInventors: Sheng QIANG, Chanjuan MAO, Shiguo CHEN, Weimin DAI, Xiaoling SONG
-
Publication number: 20160312287Abstract: Particular aspects provide novel methods and compositions (e.g., nucleic acids, kits, etc.) having substantial utility for providing a prognosis of prostate cell proliferative disorders. In particular aspects, this is achieved by the analysis of the expression status of a panel of genes, or subsets thereof.Type: ApplicationFiled: December 23, 2015Publication date: October 27, 2016Inventors: Susan Cottrell, Fabian Model, Carolina Haefliger, Gunter Weiss, Juergen Distler, Andrew Z. Sledziewski, Xiaoling Song, Thomas L. Skillman, Jeffrey G. Thomas
-
Publication number: 20160304964Abstract: The invention provides methods, nucleic acids and kits for detecting, or for detecting and distinguishing between or among liver cell proliferative disorders or for detecting, or for detecting and distinguishing between or among colorectal cell proliferative disorders. The invention discloses genomic sequences the methylation patterns of which have utility for the improved detection of and differentiation between said class of disorders, thereby enabling the improved diagnosis and treatment of patients.Type: ApplicationFiled: March 23, 2016Publication date: October 20, 2016Inventors: Catherine E. Lofton-Day, Andrew Z. Sledziewski, Ralf Lesche, Matthias Schuster, Juergen Distler, Reimo Tetzner, Thomas Hildmann, Fabian Model, Xiaoling Song